Notable Labs’ attempts to take a Boehringer Ingelheim cancer drug to market appear to have come to end with the ...
Ono Pharma and Boehringer Ingelheim both added to their cancer pipelines, licensing drugs from LigaChem Bio and Circle Pharma ...
The Phase III trials will evaluate survodutide in metabolic dysfunction-associated steatohepatitis (MASH), fibrosis and ...
BERLIN, Oct. 15, 2024 /PRNewswire/ -- Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to ...
Boehringer Ingelheim and Circle Pharma have signed a partnership and licence agreement focused on developing a new cancer ...
GlobalData on MSN9d
Boehringer partners WHO Foundation to advance healthcare accessBoehringer Ingelheim, in partnership with the WHO Foundation [an organisation set up to support the World Health Organization ...
Boehringer Ingelheim, Circle Pharma ink research collaboration to develop a novel precision cancer treatment: Ingelheim, Germany Friday, October 11, 2024, 12:00 Hrs [IST] Boehring ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare servic ...
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback